Age-Dependent Therapeutic Effects of Once-Daily Molsidomine Used as an Add-On Treatment in Patients with Stable Angina pectoris

Publisher： Karger

E-ISSN： 1424-0556|4|4|184-189

ISSN： 1422-9528

Source： Heart Drug, Vol.4, Iss.4, 2004-12, pp. : 184-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stable Angina Pectoris: Current Medical Treatment

By  

Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. : 1569-1580

Bentham Science Publishers

Access to resources Recommend Favorite

Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal

By Thadani Udho  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 17, 2012-12 ,pp. : 2555-2563

Informa Healthcare

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Once-Daily Molsidomine: From Immediate-Release to Prolonged-Release Once-Daily Formulations

By Herchuelz A.  

American Journal of Drug Delivery, Vol. 2, Iss. 2, 2004-01 ,pp. : 131-141

Adis International

Access to resources Recommend Favorite

Trimetazidine for stable angina pectoris

By Cross H.R.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. : 857-875

Informa Healthcare

Access to resources Recommend Favorite

Effects of Amlodipine and Isosorbide Dinitrate on Exercise-Induced and Ambulatory Ischemia in Patients with Chronic Stable Angina Pectoris

By Steffensen Rolf   Melchior Thomas   Bech Jan   Nissen Henrik   Haastrup Benedikte   Grande Peer   Rasmussen Verner   Hansen Jørgen   Skagen Knud   Haghfelt Torben  

Cardiovascular Drugs and Therapy, Vol. 11, Iss. 5, 1997-11 ,pp. : 629-635

Springer Publishing Company

Access to resources Recommend Favorite